Industries > Pharma > Global Defibrillators Market Forecast 2017-2026

Global Defibrillators Market Forecast 2017-2026

External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators

PUBLISHED: 07 December 2016
PAGES: 180
PRODUCT CODE: PHA0156
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0156 Categories: ,

The global defibrillators market is expected to grow at a CAGR of 5.3% from 2016-2020 and CAGR of 5.1% from 2020-2026. The market is expected to grow at a CAGR of 5.2% from 2016 to 2026. The market is estimated at $9.84bn in 2016, $12.07bn in 2020, and $16.29bn in 2026.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 180-page report you will receive 75 tables and 93 charts – all unavailable elsewhere.

The 180 page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Defibrillators Market Forecast 2017-2026

Report Scope

Global Defibrillators Market forecast 2017-2026

• Global Defibrillators National Market forecast 2017-2026, covering:

– North America:
• US
• Canada

– Europe:
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

– Asia-Pacific:
• Japan
• China
• India
• Rest of Asia-Pacific

– Rest of the World:
• Latin America
• Middle East
• Africa

• Global Defibrillators submarket forecasts, by product, 2017-2026:

– Implantable Cardioverter Defibrillators (ICDs)
• Transvenous ICDs (T-ICDs):

– Single-Chamber ICDs
– Dual-Chamber ICDs
– Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

• Subcutaneous ICDs (S-ICDs)

– External Defibrillators
• Manual External Defibrillators
• Automated External Defibrillators (AEDs):

– Semi-Automated External Defibrillators
– Fully-Automated External Defibrillators

• Wearable Cardioverter Defibrillators (WCDs)

• Global Defibrillators submarket forecasts, by end user, 2017-2026
– Hospitals and Cardiac Centers
– Pre-hospital Services
– Public Access
– Home Care
– Other-End User

• Analysis of the key factors driving and restraining the growth of the defibrillators market from 2017-2026

• Assessment of selected leading companies, examining recent performance and outlooks:
– Medtronic PLC
– Boston Scientific Corporation
– Biotronik SE & Co. KG
– St Jude Medical
– LivaNova PLC
– Zoll Medical Corporation
– Physio Control Inc.
– Cardiac Science Corporation
– Nihon Kohden Corporation
– Phillips Healthcare

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.

Buy our report today Global Defibrillators Market Forecast 2017-2026: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2017-2026


Download sample pages

Complete the form below to download your free sample pages for Global Defibrillators Market Forecast 2017-2026


Latest Pharma news

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Visiongain Publishes Vaccine Sales Market Report 2022-2032

Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers.

30 March 2022

READ

Categories